이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Meditation and Yogic Breathing-driven Modulation of Neurofluid Coupling and Brain Clearance (SPANDHA)

2026년 11월 5일 업데이트: Balachundhar Subramaniam, Beth Israel Deaconess Medical Center

This study will examine whether meditation and yogic breathing can alter brain fluid movement and waste clearance in healthy adults. It will also evaluate the GLYMPHOMETER, a new external forehead-worn device designed to objectively measure changes in brain fluid movement and exchange during meditation.

연구 개요

상태

아직 모집하지 않음

정황

상세 설명

The glymphatic system is a brain waste-clearance pathway that facilitates the movement of cerebrospinal fluid (CSF) and interstitial fluid and is thought to play an important role in maintaining brain homeostasis. Emerging evidence suggests that respiration, autonomic activity, and changes in cerebral blood flow may influence CSF dynamics and related neurofluid processes. However, the effects of voluntary breathing practices and meditation on these physiological mechanisms in humans remain incompletely understood.

The SPANDHA study will investigate whether structured yogic breathing (Pranayama; specifically Nadi Shuddhi) and/or meditation (Shoonya meditation) are associated with changes in neurofluid dynamics and related physiological measures. The study will use the GLYMPHOMETER, a forehead-mounted multimodal device designed to measure physiological signals associated with neurofluid coupling during naturalistic meditation and breathing practices. The system incorporates multi-wavelength electroencephalography (EEG) and near-infrared spectroscopy (NIRS) to characterize changes in cerebral electrical activity, cerebral hemodynamics, and neurofluid-related dynamics while participants engage in the interventions.

The study will enroll approximately 100 participants, including 50 novice and 50 experienced practitioners. Using a 2-sequence crossover, participants will complete two study visits involving meditation and yogic breathing conditions. The study will evaluate changes in measures of neurofluid dynamics, cerebral compliance, autonomic regulation including heart-rate variability (HRV), and EEG-derived brain states associated with the interventions. Participants will be stratified by experience level (novice/advance) and randomized within each stratum to one of the two intervention sequences.

A subset of participants will undergo additional validation assessments using phase-contrast magnetic resonance imaging (MRI) and blood-based biomarkers. These assessments will be used to examine the relationship between measurements obtained with the GLYMPHOMETER and established measures of CSF and cerebrovascular physiology.

The primary objective of the study is to characterize the acute physiological effects of meditation and yogic breathing on neurofluid dynamics and related brain and autonomic measures. The findings may provide preliminary evidence regarding the feasibility of using voluntary breathing and meditation practices to modulate physiological processes associated with glymphatic function and may inform future studies of non-pharmacological approaches to brain health.

연구 유형

중재적

등록 (추정된)

120

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Massachusetts
      • Boston, Massachusetts, 미국, 02215

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

25년 (성인)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Healthy adults, 25-60 years old.
  • Novice or Advanced as defined above.
  • Fluent in English.
  • Able to travel to BIDMC site for two days approximately 3-7 days apart.

Exclusion Criteria:

  • History of neurological and/or neurodegenerative disorders (e.g., epilepsy, stroke, mild cognitive impairment, dementia)
  • History of cardiovascular and respiratory illnesses
  • History of major psychiatric disorders (e.g., schizophrenia, bipolar disorder)
  • Currently diagnosed mental health issues (e.g., anxiety, depression)
  • Current use of psychoactive medications, including medications prescribed for anxiety, depression, or other psychiatric conditions, or current use of stimulants or other medications that may substantially affect central nervous system function or study outcomes.
  • Skin ailments, abrasions or contusions, particularly located on the forehead and face

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위화되지 않음
  • 중재 모델: 크로스오버 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Novice Meditators

Less than 1 year of consistent meditation practice.

Nadi Shuddhi is a structured yogic breathing practice involving slow, alternating respiration through the left and right nostrils in a prescribed sequence.

Shoonya meditation is a structured contemplative practice characterized by conscious non-doing, in which participants maintain a relaxed, alert state while minimizing deliberate attentional selection, cognitive elaboration, and engagement with internal or external stimuli.

활성 비교기: Advanced Meditators

More than 5 years or a minimum of 2500 hours of consistent meditation practice

Nadi Shuddhi is a structured yogic breathing practice involving slow, alternating respiration through the left and right nostrils in a prescribed sequence.

Shoonya meditation is a structured contemplative practice characterized by conscious non-doing, in which participants maintain a relaxed, alert state while minimizing deliberate attentional selection, cognitive elaboration, and engagement with internal or external stimuli.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Acquisition of physiological data using the GLYMPHOMETER during meditation and yogic breathing sessions.
기간: At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2

Participants meeting threshold for analyzable device recordings.

At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2

2차 결과 측정

결과 측정
측정값 설명
기간
Neurofluid-related physiological measures during Shoonya meditation and Nadi Shuddhi breathing.
기간: At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2

Changes in GLYMPHOMETER-derived measures of neurofluid coupling, during Shoonya meditation and Nadi Shuddhi breathing.

(Measurement device: Glymphometer; Measure: Neurofluid coupling aka Fluid dynamics in brain)

At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
Autonomic regulation during Shoonya meditation and Nadi Shuddhi breathing.
기간: At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2

Changes in heart-rate variability (HRV) during Shoonya meditation and Nadi Shuddhi breathing.

At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
Very-low-frequency physiological signal characteristics
기간: At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2

Changes in predefined very-low-frequency (0.001-0.1 Hz) signal characteristics derived from GLYMPHOMETER medical™ recordings and their relationship to neurofluid-related measures.

At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2

기타 결과 측정

결과 측정
측정값 설명
기간
Differences in neurophysiological responses according to meditation experience.
기간: From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.

Comparison of changes in GLYMPHOMETER-derived measures of neurofluid coupling between novice and advanced meditators.

From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
Mindful Attention Awareness Scale
기간: Once at Baseline. Estimated acquisition window: 5-8 minutes

We assess for change in Mindfulness levels by using a validated scale for this purpose namely, Mindfulness Attention Awareness Scale (MAAS). The scale measures the individuals' ability for receptive awareness and attention to present. This aids in evaluating any change on the individual's awareness levels after the Inner engineering intervention. We compute the MAAS scores for each participant which is a mean score for 15 item questionnaires and compare the pre & post intervention results to look for change. Participants are asked to rate on a scale of 1 (Almost Always) to 6 (Almost Never) to assess the frequency of occurrence of each experience. Mean is then computed using items from each of the 15 questions to create a MAAS score, ranging from 0 to 6. Higher MAAS scores indicate better mindfulness state.

Once at Baseline. Estimated acquisition window: 5-8 minutes
Meditation Depth Questionnaires
기간: At each study visit after the meditation practice is completed. Expected acquisition window: 10-15 minutes; Total number of visits: 2

This 30-item measure assesses the subjective depth of meditation across progressively deeper experiential states. Items are typically rated on a 5-point Likert scale and are grouped into five empirically derived domains: hindrances, relaxation, personal-self/concentration, essential/transpersonal qualities, and transpersonal-self/non-duality. Together, these domains capture experiences ranging from obstacles and relaxation during meditation to focused concentration, transpersonal qualities, and experiences of diminished self-boundaries or non-dual awareness.

At each study visit after the meditation practice is completed. Expected acquisition window: 10-15 minutes; Total number of visits: 2
Correlation between GLYMPHOMETER-derived neurofluid metrics and MRI-based neurofluid dynamics (Validation of Portable Device).
기간: From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.

This outcome evaluates the concurrent validity of the portable device against the gold standard. The statistical method will be a correlation analysis (Pearson or Spearman, as appropriate based on data distribution).

  • Measurement 1 (Variable A): Neurofluid coupling oscillations measured via the GLYMPHOMETER medical™ device (measured as relative changes in HbO, HbR, HbT, and CSF/H2O proportional signal including interhemispheric correlation coefficient across these neurofluid compartments while gating each of them to very low frequency, respiratory and cardiac frequency bands).
  • Measurement 2 (Variable B): Global neurofluid dynamics and CSF flow measured via 3T MRI using fast fMRI and phase-contrast sequences (measured as BOLD-CSF coupling magnitude and CSF stroke volume in mL).
  • Assessment: The study will assess the correlation between the magnitude of oscillatory coupling in Measurement 1 with the absolute flow dynamics in Measurement 2 during the designated validation windows.
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
Correlation between GLYMPHOMETER-derived neurofluid metrics and plasma brain-derived biomarkers.
기간: From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.

This outcome evaluates the relationship between neurofluid dynamics and blood-based markers of brain clearance. The statistical method will be a correlation analysis (Pearson or Spearman).

  • Measurement 1 (Variable A): Neurofluid coupling oscillations measured via the GLYMPHOMETER medical™ device (measured as relative changes in HbO, HbR, HbT, and CSF/H2O proportional signal including interhemispheric correlation coefficient across these neurofluidic compartments while gating each of them to very low frequency, respiratory and cardiac frequency bands).
  • Measurement 2 (Variable B): Plasma concentrations of brain-derived proteins/peptides (Aβ40, Aβ42, total/phosphorylated tau, NF-L, GFAP) measured via ultra-sensitive Simoa immunoassay (measured in pg/mL).
  • Assessment: The study will assess the correlation between acute GLYMPHOMETER-derived neurofluid changes and plasma biomarker concentrations before and after intervention.
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
Qualitative assessment of meditation and breathing experiences.
기간: At each study visit after the meditation practice is completed. Expected acquisition window: 30 minutes; Total number of visits: 2

Qualitative characterization of participant experiences using one-on-one micro-phenomenological interviews.

At each study visit after the meditation practice is completed. Expected acquisition window: 30 minutes; Total number of visits: 2

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 16일

기본 완료 (추정된)

2027년 11월 30일

연구 완료 (추정된)

2028년 4월 30일

연구 등록 날짜

최초 제출

2026년 9월 15일

QC 기준을 충족하는 최초 제출

2026년 10월 23일

처음 게시됨 (실제)

2026년 10월 29일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 10일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 5일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 2026P000655
  • GRT69415 (기타 보조금/기금 번호: Inner Science Research Foundation)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다